MedTrace Logo

Evaluate the Effectiveness and Safety of a Cryogenic Pen to Treat Skin Tags Versus a Comparator.

NCT07355543 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-01-21

No results posted yet for this study

Summary

The purpose of this clinical investigation is to evaluate the effectiveness and safety of Nitrofreeze Skin Tag for the treatment of skin tags versus a comparator device (Scholl Freeze Away® Skin Tag Remover).

Conditions

  • Skin Tags

Interventions

DEVICE

NITROFREEZE Skin tag

Treatment of the skin tag with NITROFREEZE Skin Tag device on Day 0, Day 15, Day 30.

DEVICE

Scholl Freeze Away Skin Tag Remover

Treatment of the skin tag with Scholl Freeze Away Skin Tag Remover device on Day 0, Day 15, Day 30.

Sponsors & Collaborators

  • Eurofins Dermscan Pharmascan

    collaborator INDUSTRY

  • Oystershell NV

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-06
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07355543 on ClinicalTrials.gov